San Diego, CA, United States of America

Steven T Sakata


Average Co-Inventor Count = 5.6

ph-index = 9

Forward Citations = 232(Granted Patents)


Location History:

  • Richmond, CA (US) (1998)
  • San Diego, CA (US) (2000 - 2008)

Company Filing History:


Years Active: 1998-2008

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Steven T. Sakata

Introduction

Steven T. Sakata is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that act as inhibitors for various biological pathways. With a total of 11 patents to his name, Sakata's work has the potential to impact the treatment of numerous medical conditions.

Latest Patents

Sakata's latest patents include innovative compounds such as isothiazoloanthrones, isoxazoloanthrones, and isoindolanthrones, along with their derivatives. These compounds are recognized for their role as JNK inhibitors, which are crucial in various therapeutic applications. His patents detail methods of using indazole derivatives as selective inhibitors of JNK, showcasing their utility in treating conditions responsive to JNK inhibition. The pharmaceutical compositions he developed contain one or more of these compounds, highlighting their potential in medical treatments.

Career Highlights

Throughout his career, Steven T. Sakata has worked with notable companies in the pharmaceutical industry, including Signal Pharmaceuticals, Inc. and Berlex Laboratories, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in drug discovery.

Collaborations

Sakata has collaborated with esteemed colleagues such as Kenneth Jay Shaw and Zuchun Zhao. These partnerships have fostered an environment of innovation and have led to the advancement of various projects in the pharmaceutical sector.

Conclusion

Steven T. Sakata's contributions to the field of pharmaceuticals through his innovative patents and collaborations have established him as a key figure in the development of JNK inhibitors. His work continues to pave the way for new treatments and advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…